Page last updated: 2024-09-03

fullerene c60 and 5-carboxytetramethylrhodamine succinimidyl ester

fullerene c60 has been researched along with 5-carboxytetramethylrhodamine succinimidyl ester in 1 studies

Compound Research Comparison

Studies
(fullerene c60)
Trials
(fullerene c60)
Recent Studies (post-2010)
(fullerene c60)
Studies
(5-carboxytetramethylrhodamine succinimidyl ester)
Trials
(5-carboxytetramethylrhodamine succinimidyl ester)
Recent Studies (post-2010) (5-carboxytetramethylrhodamine succinimidyl ester)
3,80652,1701850112

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broaddus, WC; Chen, ZJ; Cooper, P; Corwin, F; Dorn, HC; Fatouros, PP; Fillmore, HL; Ge, J; Henderson, SC; Hirsch, JI; Shu, CY; Shultz, MD; Wilson, J; Zhang, J1

Other Studies

1 other study(ies) available for fullerene c60 and 5-carboxytetramethylrhodamine succinimidyl ester

ArticleYear
Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors.
    Nanomedicine (London, England), 2011, Volume: 6, Issue:3

    Topics: Amino Acid Sequence; Animals; Brain Neoplasms; Contrast Media; Coordination Complexes; Drug Delivery Systems; Fullerenes; Glioblastoma; Humans; Interleukin-13; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Sequence Data; Nanoshells; Peptides; Receptors, Interleukin-13; Rhodamines

2011